Cytokeratins in papillary lesions of the breast: Is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?

American Journal of Surgical Pathology

Volumn 29, Issue 5, 2005, Pages 625-632

  Tan, Puay Hoon ^a   Aw, Meng Yuan ^b   Yip, George ^b   Bay, Boon Huat ^b   Sii, Lang Hiong ^a   Murugaya, Sivakumar ^a   Tse, Gary M ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Confocal microscopy; Cytokeratin immunohistochemistry; Immunoscore; Papillary DCIS; Papilloma

Indexed keywords

CYTOKERATIN; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST PAPILLOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; DIFFERENTIAL DIAGNOSIS; FEMALE; HONG KONG; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PREDICTION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SINGAPORE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MAMMARY GLANDS, HUMAN; MIDDLE AGED; PAPILLOMA, INTRADUCTAL; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 17744391388     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000157941.88161.39     Document Type: Article

References (25)

1. Abd El-Rehini DM, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004;203:661-671.
2. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol. 2001;25:1054-1060.
3. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin: I. Normal breast and benign prolifenitive lesions. Virchows Arch A Pathol Anal Histopathol. 1992;421:315-322.
4. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin: II. Epitheliosis and ductal carcinoma in situ. Virchows Arch A Pathol Anat Histopathol. 1992;421:323-330.
5. Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high molecular-weight cytokeratin expression patterns. J Pathol. 2001;195:415-421.
6. Going JJ. Stages in the way to breast cancer. J Pathol. 2003;199:1-3.
7. Gottlieb C, Raju U, Greenwald KA. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study. Mod Pathol. 1990;3:135-140.
8. Heatley M, Maswell P, Whiteside C, et al. Cytokeratin intermediate filament expression in benign and malignant breast disease. J Clin Pathol. 1995;48:26-32.
9. Jarasch ED, Nagle RB, Kaufman M, et al. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol. 1988;19:276-289.
10. Kirfel J, Magin TM, Reichelt J. Keratins a structural scaffold with emerging functions. Cell Mol Life Sci. 2002;60:56-71.
11. Lacroix-Triki M, Mery E, Voigt JJ, et al. Value of cytokcratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intra epithelial lesions of the breast: a comparative study with 34betaE12 antibody. Virchows Arch. 2003;442:548-554.
12. Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol. 2004;28:1076-1091.
13. MacGrogan G, Moinfar F, Raju U. Intraductal papillary neoplasms. In: Tavassoli FA, Devilee P eds. Pathology & Genetics: Tumours of the Breast and Female Genital Organs. Lyon, France: TARC Press, 2003:76-80.
14. Malzahn K, Mitze M, Thoenes M, et al. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch. 1998;433:119-129.
15. Masood S, Sim SJ, Lu L. Immunohistochemical differentiation of ADH vs carcinoma in situ of the breast. Cancer Detec Prev. 1992;16:225-235.
16. Moinfar F, Man YG, Lininger RA. Use of 34βE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type: benign and malignant intraductal proliferations. Am J Surg Pathol. 1999;23:1048-1058.
17. Otterbach F, Bankfalvi A, Bergner S. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations if the breast. Histopathology. 2000;37:232-240.
18. Raju U, Lee MW, Zarbo RJ, et al. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod Pathol. 1989;2: 569-576.
19. Raju U, Crissman JD, Zarbo RJ, et al. Epitheliosis of the breast: an immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast. Am J Surg Pathol. 1990;14:939-947.
20. Raju U, Vertes D. Breast papillomas with atypical ductal hyperplasia: a clinicopathologic study. Hum Pathol. 1996;27:1231-1238.
21. Sloane JP, Anderson TJ, Blarney RW, et al. Pathology Reporting in Breast Cancer Screening, 2nd ed [NHSBSP publication no. 3]. Sheffield: National Coordinating Group for Breast Screening Pathology, 1995:19-21.
22. Tan PH, Lui GG, Chiang G, et al. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions. Histopathology. 2004;45:1-9.
23. Tsubura A, Okada H, Senzaki H, et al. Keratin expression in the normal breast and in breast carcinoma. Histopathology. 1991;18:517-522.
24. Werling RW, Hwang H, Yajizi H, et al. Immunohistochemical distinction of invasive from non-invasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol. 2003;27:82-90.
25. Wetzels RHW, Kuijpers HJH, Lane EB. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol. 1991; 138:751-763.